Prenatal diagnosis of fetal bradyarrhythmia and postnatal outcome
- PMID: 37838306
- PMCID: PMC10928005
- DOI: 10.1016/j.ipej.2023.10.003
Prenatal diagnosis of fetal bradyarrhythmia and postnatal outcome
Abstract
Introduction: Prenatal diagnosis of Fetal bradyarrhythmia leads to parental and care provider anxiety as data on outcome is scarce. We aimed to correlate the prenatal presentation of fetal bradyarrhythmia with postnatal outcome.
Methods: Retrospective analysis of case records from 2017 to 2021. All fetuses with sustained bradyarrhythmia beyond 11 weeks were included in the study.
Results: Twenty fetuses were identified: mean gestational age at diagnosis was 23 weeks 2 days. The type of bradyarrhythmia was as follows: Complete atrioventricular block 10 (50 %), Sinus Bradycardia 7 (35 %), second degree atrioventricular block 2 (10 %), and Unclassified 1 (5 %). In 10 fetuses, cardiac and extracardiac anatomy were normal; 8 fetuses (40 %) had cardiac anomalies,1 fetus had intraventricular hemorrhage and 1 had nuchal cystic hygroma. Among the fetuses with associated anomalies, there were 5 terminations of pregnancy (TOP), 1 intrauterine fetal demise (IUD), 3 neonatal demise (NND) and 1 livebirth. Among fetuses with normal anatomy, there were 2 TOP and 8 livebirths; five of the 10 mothers (50 %) tested positive for Anti Ro/La antibodies. All the 6 liveborn fetuses with complete atrioventricular block are on conservative management: 2 on metaproterenol and 4 on clinical follow up. Nine out of the 10 cases that had a postnatal paediatric cardiology assessment had a correct prenatal diagnosis.
Conclusion: Correct prenatal identification of fetal bradyarrhythmia is feasible in about 90 % of cases. The risk of postnatal pacemaker requirement appears to be low irrespective of maternal Anti Ro/La status.
Keywords: Antenatal steroids; Atrioventricular block; Congenital heart disease; Fetal bradyarrhythmia; Pacemaker.
Copyright © 2023 Indian Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.Circulation. 2009 Apr 14;119(14):1867-72. doi: 10.1161/CIRCULATIONAHA.108.773143. Epub 2009 Mar 30. Circulation. 2009. PMID: 19332471
-
Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):167-71. doi: 10.1016/j.ejogrb.2005.01.013. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16219517
-
Isolated non-immune-mediated second-degree atrioventricular block in the fetus: natural history and predictive factors for spontaneous recovery.Ultrasound Obstet Gynecol. 2024 Oct;64(4):486-492. doi: 10.1002/uog.27662. Ultrasound Obstet Gynecol. 2024. PMID: 38642334
-
Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Curr Opin Rheumatol. 2009. PMID: 19584727 Review.
-
Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2019 Jan;53(1):36-46. doi: 10.1002/uog.20114. Ultrasound Obstet Gynecol. 2019. PMID: 30207011
References
-
- Caruso E., Farruggio S., Agati S., Mambro C. Fetal bradyarrhythmias: etiopathogenesis, diagnosis and treatment: between literature review and experience of a tertiary center. Congenit Heart Dis. 2021;16 doi: 10.32604/CHD.2021.015470. - DOI
LinkOut - more resources
Full Text Sources
Research Materials